Rayont, Inc. Stock Other OTC
Equities
RAYT
US75508M1009
Biotechnology & Medical Research
Sales 2021 | 2.97M 4.06M | Sales 2022 | 2.84M 3.88M | Capitalization | 45.69M 62.44M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | 47.8 x |
Net Debt 2021 | 2.4M 3.29M | Net Debt 2022 | 7.78M 10.63M | EV / Sales 2022 | 18.8 x |
P/E ratio 2021 |
293
x | P/E ratio 2022 |
186
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.18% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 20-03-30 | |
Ilenna Copley
COO | Chief Operating Officer | - | 22-05-15 |
Dhurata Toli
BRD | Director/Board Member | 48 | 21-03-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jason Sunstein
BRD | Director/Board Member | 52 | 22-04-20 |
Dhurata Toli
BRD | Director/Board Member | 48 | 21-03-24 |
Chief Executive Officer | 48 | 20-03-30 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |